These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21507822)

  • 21. Role theory: literature review and implications for patient-pharmacist interactions.
    Guirguis LM; Chewning BA
    Res Social Adm Pharm; 2005 Dec; 1(4):483-507. PubMed ID: 17138492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists need recognition as providers to enhance patient care.
    White CM
    Ann Pharmacother; 2014 Feb; 48(2):268-73. PubMed ID: 24259647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review.
    Dwiputri AW; Pristianty L; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31971912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings.
    Chua SS; Kok LC; Yusof FA; Tang GH; Lee SW; Efendie B; Paraidathathu T
    BMC Health Serv Res; 2012 Nov; 12():388. PubMed ID: 23145922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH).
    Edwards HD; Webb RD; Scheid DC; Britton ML; Armor BL
    Am J Med Qual; 2012; 27(6):529-34. PubMed ID: 22679128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses.
    Lee JK; Slack MK; Martin J; Ehrman C; Chisholm-Burns M
    J Am Geriatr Soc; 2013 Jul; 61(7):1119-27. PubMed ID: 23796001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pharmacist interventions on health-related quality of life.
    Pickard AS; Johnson JA; Farris KB
    Ann Pharmacother; 1999 Nov; 33(11):1167-72. PubMed ID: 10573313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the quality of pharmaceutical care. II. Application of concepts of quality assessment from medical care.
    Farris KB; Kirking DM
    Ann Pharmacother; 1993 Feb; 27(2):215-23. PubMed ID: 8439702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists performing quality spirometry testing: an evidence based review.
    Cawley MJ; Warning WJ
    Int J Clin Pharm; 2015 Oct; 37(5):726-33. PubMed ID: 26148860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level of awareness regarding diabetes and its management in diabetic population of Pakistan, and highlighting the role of consultant pharmacist.
    Zia-ur-Rahman ; Khan I; Gaohar QY; Baig A; Khan FA
    J Pak Med Assoc; 2014 May; 64(5):574-5. PubMed ID: 25272548
    [No Abstract]   [Full Text] [Related]  

  • 31. Connected health care: the future of health care and the role of the pharmacist.
    Barr PJ; McElnay JC; Hughes CM
    J Eval Clin Pract; 2012 Feb; 18(1):56-62. PubMed ID: 20698917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice.
    Nkansah NT; Brewer JM; Connors R; Shermock KM
    Am J Health Syst Pharm; 2008 Jan; 65(2):145-9. PubMed ID: 18192260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a pharmacist-managed diabetes program.
    Jennings BT; Marx CM
    Am J Health Syst Pharm; 2012 Nov; 69(22):1951-3. PubMed ID: 23135560
    [No Abstract]   [Full Text] [Related]  

  • 34. Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management.
    Henry TM; Smith S; Hicho M
    Hosp Pharm; 2013 Sep; 48(8):656-61. PubMed ID: 24421536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to the components of the Fleetwood model: self-reported process measures in the Fleetwood Phase III study.
    Lapane KL; Hughes CM
    Consult Pharm; 2006 Dec; 21(12):981-7. PubMed ID: 17243849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "The Impact of Pharmacists Engaged in Collaborative Practice Agreements in the United States".
    Kerelos T; Gangoo-Dookhan T
    J Pharm Pract; 2023 Dec; 36(6):1480-1484. PubMed ID: 35852959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practicing Your Compounding Skills Outside of Your Pharmacy's Walls.
    Gonzalez M
    Int J Pharm Compd; 2015; 19(3):205-7, 208-11. PubMed ID: 26714361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Steps aimed at upgrading a pharmaceutical care sector: the case of surgery].
    Guérin A; Thibault M; Nguyen C; Lebel D; Bussières JF
    Ann Pharm Fr; 2014 Jul; 72(4):267-86. PubMed ID: 24997888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computerized monitoring protocols as a pharmaceutical care practice enhancement: a conceptual illustration using diabetes mellitus.
    Boyd AF; Hartzema AG
    Ann Pharmacother; 1993; 27(7-8):963-6. PubMed ID: 8364283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management.
    Conley MP; Chim C; Magee CE; Sullivan DJ
    Curr Diab Rep; 2014 Mar; 14(3):470. PubMed ID: 24496918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.